Cargando…
Posttreatment M‐Protein Nadir Level Is a Significant Prognostic Factor Associated with Survival in Multiple Myeloma
In the present study 142 patients with myeloma (102 with IgG M‐protein and 40 with IgA) treated with either VMCP (65 patients) or MMCP (77 patients) as remission induction therapy were retrospectively analyzed. Response to treatment was evaluated in terms of a more‐than‐50% fall of pretreatment M‐pr...
Autores principales: | Shimizu, Kazuyuki, Kamiya, Osamu, Hirabayashi, Noriyuki, Ichikawa, Atsushi, Kawashima, Kohei, Kobayashi, Masahide, Mizuno, Harumitsu, Nagura, Eiichi, Nitta, Masakazu, Saito, Hidehiko, Sao, Hiroshi, Shibata, Toshihiko, Takeyama, Hideo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926063/ https://www.ncbi.nlm.nih.gov/pubmed/10359052 http://dx.doi.org/10.1111/j.1349-7006.1999.tb00755.x |
Ejemplares similares
-
Multi‐drug Combination Therapy with Vincristine‐Melphalan‐Cyclophosphamide‐Prednisolone Was More Effective than Cyclophosphamide‐Prednisolone in Stage III Myeloma
por: Shimizu, Kazuyuki, et al.
Publicado: (1990) -
Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer
por: Tomioka, Atsushi, et al.
Publicado: (2014) -
The leucocyte nadir, a predictor of chemotherapy efficacy?
por: Kvinnsland, S
Publicado: (1999) -
Reaching the Nadir of Medication Overuse in Chronic Migraine
por: Onan, Dilara, et al.
Publicado: (2022) -
Combined Pre- and Posttreatment of Paraoxon Exposure
por: Lorke, Dietrich E, et al.
Publicado: (2020)